|
1
|
Songer MN, Rauschning W, Carson EW and
Pandit SM: Analysis of peridural scar formation and its prevention
after lumbar laminotomy and discectomy in dogs. Spine (Phila Pa
1976). 20:571–580. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burton CV, Kirkaldy-Willis WH, Yong-Hing K
and Heithoff KB: Causes of failure of surgery on the lumbar spine.
Clin Orthop Relat Res. 191–199. 1981.PubMed/NCBI
|
|
3
|
North RB, Campbell JN, James CS,
Conover-Walker MK, Wang H, Piantadosi S, Rybock JD and Long DM:
Failed back surgery syndrome: 5-year follow-up in 102 patients
undergoing repeated operation. Neurosurgery. 28:685–691. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee HM, Yang KH, Han DY and Kim NH: An
experimental study on prevention of postlaminectomy scar formation.
Yonsei Med J. 31:359–366. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abitbol JJ, Lincoln TL, Lind BI, Amiel D,
Akeson WH and Garfin SR: Preventing postlaminectomy adhesion. A new
experimental model. Spine (Phila Pa 1976). 19:1809–1814. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Preul MC, Campbell PK, Garlick DS and
Spetzler RF: Application of a new hydrogel dural sealant that
reduces epidural adhesion formation: Evaluation in a large animal
laminectomy model. J Neurosurg Spine. 12:381–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Darzynkiewicz Z, Bruno S, Del Bino G and
Traganos F: The cell cycle effects of camptothecin. Ann N Y Acad
Sci. 803:93–100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang R, Li Y, Cai Q, Liu T, Sun H and
Chambless B: Preclinical pharmacology of the natural product
anticancer agent 10-hydroxycamptothecin, an inhibitor of
topoisomerase I. Cancer Chemother Pharmacol. 41:257–267. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beretta GL, Perego P and Zunino F:
Mechanisms of cellular resistance to camptothecins. Curr Med Chem.
13:3291–3305. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang SL, Lin SY, Hsieh TF and Chan SA:
Thermal behavior and thermal decarboxylation of
10-hydroxycamptothecin in the solid state. J Pharm Biomed Anal.
43:457–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mori M, Triboulet R, Mohseni M,
Schlegelmilch K, Shrestha K, Camargo FD and Gregory R: Hippo
signaling regulates microprocessor and links cell-density-dependent
miRNA biogenesis to cancer. Cell. 156:893–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi R, O'Carroll D, Pasolli HA, Zhang Z,
Dietrich FS, Tarakhovsky A and Fuchs E: Morphogenesis in skin is
governed by discrete sets of differentially expressed microRNAs.
Nat Genet. 38:356–362. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hildebrand J, Rütze M, Walz N, Gallinat S,
Wenck H, Deppert W, Grundhoff A and Knott A: A comprehensive
analysis of microRNA expression during human keratinocyte
differentiation in vitro and in vivo. J Invest Dermatol. 131:20–29.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ham O, Song BW, Lee SY, Choi E, Cha MJ,
Lee CY, Park JH, Kim IK, Chang W, Lim S, et al: The role of
microRNA-23b in the differentiation of MSC into chondrocyte by
targeting protein kinase A signaling. Biomaterials. 33:4500–4507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang KC, Garmire LX, Young A, Nguyen P,
Trinh A, Subramaniam S, Wang N, Shyy JY, Li YS and Chien S: Role of
microRNA-23b in flow-regulation of Rb phosphorylation and
endothelial cell growth. Proc Natl Acad Sci USA. 107:3234–3239.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salvi A, Sabelli C, Moncini S, Venturin M,
Arici B, Riva P, Portolani N, Giulini SM, De Petro G and Barlati S:
MicroRNA-23b mediates urokinase and c-met downmodulation and a
decreased migration of human hepatocellular carcinoma cells. FEBS
J. 276:2966–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Liu Z, Chen L, Zhou L and Yao Y:
MicroRNA-23b is an independent prognostic marker and suppresses
ovarian cancer progression by targeting runt-related transcription
factor-2. FEBS Lett. 588:1608–1615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiyomaru T, Seki N, Inoguchi S, Ishihara
T, Mataki H, Matsushita R, Goto Y, Nishikawa R, Tatarano S, Itesako
T, et al: Dual regulation of receptor tyrosine kinase genes EGFR
and c-Met by the tumor-suppressive microRNA-23b/27b cluster in
bladder cancer. Int J Oncol. 46:487–496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Xu X, Wang J, Lin J and Chen W:
Identifying miRNA/mRNA negative regulation pairs in colorectal
cancer. Sci Rep. 5:129955015. View Article : Google Scholar
|
|
22
|
Ell B, Qiu Q, Wei Y, Mercatali L, Ibrahim
T, Amadori D and Kang Y: The microRNA-23b/27b/24 cluster promotes
breast cancer lung metastasis by targeting metastasis-suppressive
gene prosaposin. J Biol Chem. 289:21888–21895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Sun Y, Chen H, Zhu G, Liang Y, Wang
Q, Wang J and Yan L: Hydroxycamptothecin induces apoptosis of
fibroblasts and prevents intraarticular scar adhesion in rabbits by
activating the IRE-1 signal pathway. Eur J Pharmacol. 781:139–147.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Chen H, Sun Y, Dai J, Wang S, Wang J
and Yan L: Hydroxycamptothecin prevents intraarticular scar
adhesion by activating the PERK signal pathway. Eur J Pharmacol.
810:36–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin X, Sun H, Yu D, Liang Y, Yuan Z and Ge
Y: Hydroxycamptothecin induces apoptosis of human tenon's capsule
fibroblasts by activating the PERK signaling pathway. Invest
Ophthalmol Vis Sci. 54:4749–4758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JY, Stenzel W, Löhr M, Stützer H,
Ernestus RI and Klug N: The role of mitomycin C in reducing
recurrence of epidural fibrosis after repeated operation in a
laminectomy model in rats. J Neurosurg Spine. 4:329–333. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yildiz KH, Gezen F, Is M, Cukur S and
Dosoglu M: Mitomycin C, 5-fluorouracil, and cyclosporin A prevent
epidural fibrosis in an experimental laminectomy model. Eur Spine
J. 16:1525–1530. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sandoval MA and Hernandez-Vaquero D:
Preventing peridural fibrosis with nonsteroidal anti-inflammatory
drugs. Eur Spine J. 17:451–455. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tao H and Fan H: Implantation of amniotic
membrane to reduce postlaminectomy epidural adhesions. Eur Spine J.
18:1202–1212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Wang L, Sun S, Liu B, Wu N and Cao
X: The effect of 10-hydroxycamptothecine in preventing fibroblast
proliferation and epidural scar adhesion after laminectomy in rats.
Eur J Pharmacol. 593:44–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zunino F and Pratesi G: Camptothecins in
clinical development. Expert Opin Investig Drugs. 13:269–284. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ulukan H and Swaan PW: Camptothecins: A
review of their chemotherapeutic potential. Drugs. 62:2039–2057.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gammell P: MicroRNAs: Recently discovered
key regulators of proliferation and apoptosis in animal cells:
Identification of miRNAs regulating growth and survival.
Cytotechnology. 53:55–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen M, Shi J, Zhang W, Huang L, Lin X, Lv
Z, Zhang W, Liang R and Jiang S: MiR-23b controls TGF-β1 induced
airway smooth muscle cell proliferation via direct targeting of
Smad3. Pulm Pharmacol Ther. 42:33–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Hao W, Wang X and Su H: miR-23b
targets Smad 3 and ameliorates the LPS-inhibited osteogenic
differentiation in preosteoblast MC3T3-E1 cells. J Toxicol Sci.
41:185–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang X, Yang J, Zhao J, Zhang P and Huang
X: MicroRNA-23b inhibits the proliferation and migration of
heat-denatured fibroblasts by targeting Smad3. PLoS One.
10:e01318672015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leone V, D'Angelo D, Pallante P, Croce CM
and Fusco A: Thyrotropin regulates thyroid cell proliferation by
up-regulating miR-23b and miR-29b that target SMAD3. J Clin
Endocrinol Metab. 97:3292–3301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He W, Che H, Jin C and Ge S: Effects of
miR-23b on hypoxia-induced cardiomyocytes apoptosis. Biomed
Pharmacother. 96:812–817. 2017. View Article : Google Scholar : PubMed/NCBI
|
